{{Rsnum
|rsid=2298826
|Gene=SLC6A5
|Chromosome=11
|position=20638211
|Orientation=plus
|GMAF=0.3797
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SLC6A5
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 6.2 | 50.4 | 43.4
| HCB | 29.9 | 46.7 | 23.4
| JPT | 31.9 | 49.6 | 18.6
| YRI | 6.8 | 43.5 | 49.7
| ASW | 12.3 | 40.4 | 47.4
| CHB | 29.9 | 46.7 | 23.4
| CHD | 25.7 | 56.0 | 18.3
| GIH | 5.0 | 29.7 | 65.3
| LWK | 17.3 | 40.9 | 41.8
| MEX | 12.1 | 31.0 | 56.9
| MKK | 14.8 | 52.9 | 32.3
| TSI | 8.9 | 31.7 | 59.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=20859245
|Title=Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}